Cell culture has advanced to a great extent with production of recombinant proteins in g/l quantities at 10,000 L scale and beyond becoming routine. In addition, developments such as the cell culture based flu vaccine promises more advances to come in the vaccine arena. Fundamental improvements in all steps from vector construction/transfection, cell line development, media development, bioreactor operation & process control, scale-up, etc have been key for these advances and studies in these areas are within scope and welcome for this session.
08:30 AM
Udo Reichl, Andreas Bock, Aljoscha Wahl, Jana Schwarzer
08:50 AM
Jeffrey S. Larsen, Wayne R. Curtis
09:10 AM
Diane M. Wuest, Polina Rapoport, Deborah Pascoe
09:30 AM
Wen-Lin Tsai, Jennifer L. Autsen, Terrence Allotta, Judy H. Chou
09:50 AM
10:00 AM
Jeffrey C. Swanberg, Kelvin Lee
10:20 AM
Efren Pacis, Feng Li, Darren Brown, Robert Bayer
10:40 AM
Vijay Yabannavar, Brian Albarran, Jackie McGourty, Richard Lowe